Nuveen International Dividend Growth Fund Class C (NUICX)
Fund Assets | 4.51M |
Expense Ratio | 1.90% |
Min. Investment | $3,000 |
Turnover | n/a |
Dividend (ttm) | 0.97 |
Dividend Yield | 3.34% |
Dividend Growth | 103.39% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Dec 16, 2024 |
Previous Close | 28.85 |
YTD Return | 3.68% |
1-Year Return | 2.22% |
5-Year Return | 40.04% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 44 |
Inception Date | Jun 11, 2012 |
About NUICX
The Fund's investment strategy focuses on International with 1.9% total expense ratio. The minimum amount to invest in Nuveen Investment Trust II: Nuveen Santa Barbara International Dividend Growth Fund; Class C Shares is $3,000 on a standard taxable account. Nuveen Investment Trust II: Nuveen Santa Barbara International Dividend Growth Fund; Class C Shares seeks an attractive total return comprised of income from dividends and long-term capital appreciation. NUICX invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in non-US dividend-paying equity securities, which include preferred securities.
Performance
NUICX had a total return of 2.22% in the past year. Since the fund's inception, the average annual return has been 3.78%, including dividends.
Top 10 Holdings
41.05% of assetsName | Symbol | Weight |
---|---|---|
SAP SE | SAP | 5.28% |
Taiwan Semiconductor Manufacturing Company Limited | TSM | 4.97% |
Sanofi | SAN | 4.56% |
ITOCHU Corporation | 8001 | 4.35% |
BAE Systems plc | BA | 4.20% |
Macquarie Group Limited | MQG | 3.94% |
Hikma Pharmaceuticals PLC | HIK | 3.72% |
Enbridge Inc. | ENB | 3.43% |
Novo Nordisk A/S | NOVO.B | 3.32% |
ORIX Corporation | 8591 | 3.28% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 16, 2024 | $0.5826 | Dec 17, 2024 |
Sep 30, 2024 | $0.0844 | Oct 1, 2024 |
Jun 28, 2024 | $0.2181 | Jul 1, 2024 |
Mar 28, 2024 | $0.0802 | Apr 1, 2024 |
Dec 28, 2023 | $0.1073 | Dec 29, 2023 |
Dec 15, 2023 | $0.0221 | Dec 18, 2023 |